Protagonist Therapeutics (PTGX) Q2 2026 Earnings

5MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.63
-0.4
-0.18
0.05

Details

Expected EPS
-0.500389
Actual EPS
0.05
Surprise EPS
0.55
Surprise Percent
+109.99%

Description

Protagonist Therapeutics (PTGX) has reported earnings of 0.05 per share for Q2 2026.

0 Comments

Share your thoughts